REFERENCES
- Fojo A.T., Ueda K., Slamon D.J., Poplack D.G., Gottesman M.M., Pastan I. Expression of a Multidrug-Resistance Gene in Human Tumors and Tissues. Proc. Natl Acad. Sci. USA 1987; 84: 265–269
- Biedler J. Genetic Aspects of Multidrug Resistance. Cancer 1992; 70: 1799–1809
- Makris A., Powles T.J., Allred D.C., Ashley S.E., Trott P.A., Ormerod M.G., Titley J.C., Dowsett M. Quantitative Changes in Cytological Molecular Markers During Primary Medical Treatment of Breast Cancer: A Pilot Study. Breast Cancer Res. Treat. 1999; 53: 51–59
- Clahsen P.C., van de Velde C.J., Duval C., Pallud C., Mandard A.M., Delobelle-Deroide A., van den Broek L., van de Vijver M.J. The Utility of Mitotic Index, Oestrogen Receptor and Ki-67 Measurements in the Creation of Novel Prognostic Indices for Node-Negative Breast Cancer. Eur. J. Surg. Oncol. 1999; 25: 356–363
- Caffo O., Doglioni C., Veronese S., Bonzanini M., Marchetti A., Buttitta F., Fina P., Leek R., Morelli L., Palma P.D., Harris A.L., Barbareschi M. Prognostic Value of p21(WAF1) and p53 Expression in Breast Carcinoma: An Immunohistochemical Study in 261 Patients with Long-term Follow-up. Clin. Cancer Res. 1996; 2: 1591–1599
- Dublin E.A., Miles D.W., Rubens R.D., Smith P., Barnes D.M. p53 Immunohistochemical Staining and Survival After Adjuvant Chemotherapy For Breast Cancer. Int. J. Cancer 1997; 74: 605–608
- Hendrikse N.H., Franssen E.J., van der Graaf W.T., Vaalburg W., de Vries E.G. Visualization of Multidrug Resistance In Vivo. Eur. J. Nucl. Med. 1999; 26: 283–293
- Bae K.T., Piwnica Worms D. Pharmacokinetic Modeling of Multidrug Resistance P-glycoprotein Transport of Gamma-Emitting Substrates. Q. J. Nucl. Med. 1997; 41: 101–110
- Mansi L., Rambaldi P.F., Cuccurullo V., Pecori B., Quarantelli M., Fallanca F., Del Vecchio E. Diagnostic and Prognostic Role of 99mTc-Tetrofosmin in Breast Cancer. Q. J. Nucl. Med. 1997; 41: 39–250
- Ballinger J.R., Bannerman J., Boxen I., Firby P., Hartman N.G., Moore M.J. Technetium-99m-Tetrofosmin as a Substrate for P-glycoprotein: In Vitro Studies in Multidrug-resistant Breast Tumor Cells. J. Nucl. Med. 1996; 37: 1578–1582
- Epstein J., Xiao H., Oba B.K. P-glycoprotcin Expression in Plasma Cell Myeloma is Associated with Resistance to VAD. Blood 1989; 74: 913–917
- Marie J.P., Zittoun R., Sikic B.I. Multidrug Resistance (mdr) Gene Expression in Adult Acute Leukemias: Correlation with Treatment Outcome and In Vitro Drug Sensitivity. Blood 1991; 78: 586–592
- Del Vecchio S., Stoppelli M.P., Carriero M.V., Fonti R., Massa O., Li P.Y., Botti G., Cerra M., D'Aiuto G., Esposito G. Human Urokinase Receptor Concentration in Malignant and Benign Breast Tumors by In Vitro Quantitative Autoradiography: Comparison with Urokinase Levels. Cancer Res. 1993; 53: 3198–3206
- Li P.Y., Del Vecchio S., Fonti R., Carriero M.V., Potena M.I., Botti G., Miotti S., Lastoria S., Menard S., Colnaghi M.I., Salvatore M. Local Concentration of Folate Binding Protein GP38 in Sections of Human Ovarian Carcinoma by In Vitro Quantitative Autoradiography. J. Nucl. Med. 1996; 37: 665–672
- Rambaldi P.F., Mansi L., Procaccini E., Di Gregorio F., Del Vecchio E. Breast Cancer Detection with Tc-99m Tetrofosmin. Clin. Nucl. Med. 1995; 20: 703–705
- Kao C.H., Wang S.J., Liu J.C. The Use of Technetium-99m Methoxyisobutylisonitrile Breast Scintigraphy to Evaluate Palpable Breast Masses. Eur. J. Nucl. Med. 1994; 21: 432–436